By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
Additionally, the cattle sector has contributed the most to the expansion of the cattle vaccine industry in recent years.
The investment in cattle health will continue to be at the top of the agenda for policymakers.
However, the companion cattle vaccine market, which primarily includes dogs and cats, is expanding at the fastest rate.
In addition, majority of human rabies cases in India are transmitted by dogs, the government has consistently focused on the National Action Plan for Rabies, which aims to vaccinate all dogs in the country.
Attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, conjugate vaccines, recombinant vaccines, and DNA vaccines are among the categories that make up the cattle vaccine market.
The market is dominated by attenuated vaccines among these. The most prominent cattle vaccines are the Peste des petits ruminants (PPR) vaccine to combat goat plague, the Brucella vaccine to combat brucellosis, and the Foot and Mouth Disease (FMD) vaccine to protect cattle from FMD as a result of recent government initiatives under the National cattle Disease Control Programme.
The government has set aside investment for the FMD vaccine program with the goal of containing the disease and eliminating it.
The program aims to vaccinate all cattle, buffalo, sheep, goats, and pigs against FMD, as well as all bovine female calves between the ages of 4 and 8 months. Companies in the cattle vaccine industry have benefited greatly from new opportunities brought about by schemes like this one.
The India cattle vaccine market accounted for $XX Billion in 2021 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
The indigenously developed vaccine developed by the Indian Council of Agricultural Research (ICAR) against the Lumpy Skin Disease (LSD) virus, which has resulted in the deaths of approximately 50,000 cattle in several states, is expected to be available for purchase in “four to five months.”
The live attenuated vaccine, which was developed jointly by ICAR’s National Research Centre on Equines (NRCE) in Hisar, Haryana, and the Indian Veterinary Research Institute (IVRI) in Izatnagar, Uttar Pradesh, is similar to vaccines for tuberculosis, mumps, rubella, and measles.“
It is also homologous, protecting cattle at 100 percent against LSD.At this time, they only administer vaccines against the goat pox and sheep pox viruses.
Due to all three viruses belonging to the same genus of capripoxviruses, these heterologous vaccines only provide cattle with cross-protection (up to 70%) against LSD.
